Inflammation is a core focus in pharmacology and drug development, as it plays a central role in a wide range of diseases, from chronic inflammatory disorders to cancer. Inflammo-CON 2025 aims to serve as a collaborative platform for students, faculty, and researchers to present their work, exchange ideas, and drive impactful discussions on innovations in inflammation-targeted therapeutics. The conference will bring together approximately 300 delegates from across the nation, representing various disciplines within the pharmaceutical sciences.
• Preconference workshops
• Plenary Sessions
• Oral Presentations
• Poster Presentations
Inflammo-CON 2025 is an inclusive forum, welcoming:
• Undergraduate, Postgraduate and PhD students eager to network and learn from industry and academic experts.
• Researchers and academicians in pharmacology and healthcare professionals interested in the latest developments in inflammation research and other allied areas.
• Industry professionals focused on drug discovery and therapeutic development.